Genomics is opening new frontiers for precision medicine
IEEE Pulse - 03-Oct-2016A decade after the Human Genome Project was declared complete the cost to sequence DNA has plumme...
Join the club for FREE to access the whole archive and other member benefits.
VP, Head of Genomics Strategy at Optum.
Michael joined PetaGene from Seven Bridges where he was Chief Strategy Officer and General Manager of National Programmes and brings his expertise in large-scale genomics, health information technologies, and enterprise systems development. Prior to Seven Bridges Michael was Chief Scientist at Leidos and occupied several executive positions at Lockheed Martin Health & Life Sciences. He has a B.A. in Molecular Biology from the University of California, San Diego and a Ph.D. in Biomedical Sciences from the University of California, San Francisco.
Visit website: https://www.crunchbase.com/person/michael-hultner
See also: Lockheed Martin - American global aerospace, defense, security, and advanced technologies company
Details last updated 24-Dec-2020
A decade after the Human Genome Project was declared complete the cost to sequence DNA has plumme...